0 works0 citations0 h-index

Kenneth Wang

Pfizer (United States)(US)Bristol-Myers Squibb (United States)(US)

Publications by Year

Research Areas

Inflammatory Bowel Disease, Esophageal Cancer Research and Treatment, HER2/EGFR in Cancer Research, PI3K/AKT/mTOR signaling in cancer, Prenatal Screening and Diagnostics

Most-Cited Works

→ A phase two randomised trial of neratinib monotherapy versus lapatinib plus capecitabine combination therapy in patients with HER2+ advanced breast cancer(2013)151 cited
→ The Effect of Algorithms on Copy Number Variant Detection(2010)36 cited
→ Focus on…(2011)